Nanogen, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Nanogen, Inc. makes
Nanogen, Inc. manufactures diagnostic products including the StatusFirst CHF NT-proBNP test for congestive heart failure and the Real-Time PCR Internal Control 2B Set.
The company is based in the United States, and its portfolio includes devices classified as Class I and Class II that are listed in the FDA 510(k) registry.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Real-Time Pcr Internal Control 2B Set Ref K083430
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nanogen, Inc. have in the registry?
The registry currently lists 2 devices for Nanogen, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nanogen, Inc.'s devices?
Among its 2 most recently registered devices, Nanogen, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Nanogen, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Nanogen, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nanogen, Inc. in the registry?
The most recently registered devices listed for Nanogen, Inc. include STATUSFIRST CHF (CONGESTIVE HEART FAILURE) NT-PROBNP, MODEL 20204 and REAL-TIME PCR INTERNAL CONTROL 2B SET.